Cannabis stocks were little changed Thursday, and the major indices reflected a mixed bag.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, declined 0.8% to 120.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF rose 0.2% to C$9.67, while the OTCQX Cannabis index edged down 0.2% to 488.6 points.

Buds

AgraFlora Organics International Inc () (OTCMKTS:AGFAF) shares jumped after its subsidiary Farmako Limited received its UK Home Office Controlled Drug License.

With the license in hand, Farmako Limited intends to start wholesaling medical cannabis in the UK by mid-year 2020, including importing Bedrocan products from the Netherlands to the UK for patient distribution.

AgraFlora stock climbed 11.1% to C$0.10 in Toronto and nearly 14% to US$0.08 in New York.

Corp () (OTCMKTS:PEMTF) is up after its subsidiary Ihuana SAS forged a research pact with La Fundacion Universitaria de Ciencias de la Salud (The University Foundation of Health Sciences) in Bogota, Colombia. 

Ihuana and the University will cooperate in working on scientific investigations related to the medical use of cannabis products.

Shares rose 5.5% to $C0.58 on the CSE and 1.2% to US$0.44 on OTC Markets.

Duds

No one cannabis stock dragged down the sector, but a handful of companies lost ground

GrowGeneration Corp (NASDAQ:GRWG) dropped 6.4% to US$4.39, Meridian Bioscience Inc () fell 2% to US$9.58 and General Cannabis Corp () slid 2.6% to US$0.66.

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel